Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination

Neutralizing antibodies against SARS‐CoV‐2 are important to protect against infection and/or disease. Using an assay to detect antibodies directed against the receptor binding domain (RBD) of SARS‐CoV‐2 Spike, we identified individuals with SARS‐CoV‐2 infection after an outbreak at a local health in...

Descripción completa

Detalles Bibliográficos
Autores principales: Urlaub, Doris, Wolfsdorff, Natalie, Hoffmann, Jan‐Erik, Dorok, Stefanie, Hoffmann, Markus, Anft, Moritz, Pieris, Naomi, Günther, Patrick, Schaaf, Bernhard, Cassens, Uwe, Bröde, Peter, Claus, Maren, Picard, Lea K., Wingert, Sabine, Backes, Simone, Durak, Deniz, Babel, Nina, Pöhlmann, Stefan, Renken, Frank, Raunser, Stefan, Watzl, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Immunity to infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087412/
https://www.ncbi.nlm.nih.gov/pubmed/35247269
http://dx.doi.org/10.1002/eji.202149758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087412/
https://www.ncbi.nlm.nih.gov/pubmed/35247269
http://dx.doi.org/10.1002/eji.202149758

Ejemplares similares